Eric Halioua, President & CEO of PDC*line Pharma will be spaker in the Cell & Gene Therapy Innovation Leaders Summit organized, 6th - 7th Feb 2019 at Movenpick Hotel Potsdamer Platz Berlin (Germany)...
#JPM2019- The PDC*line Pharma management team will be present in full force in San Francisco during the JP Morgan Conference 2019!
Meet our CEO Eric Halioua, our CSO Joel Plumas and our COO Laurent...
Eric Halioua, President & CEO of PDC*line Pharma will be a panelist at Sachs Forum 2018, Basel.
Eric Halioua, President & CEO of PDC*line Pharma will present the company at Bio€quity Europe, May 14 – 16, 2018 in Ghent, Belgium. Flanders.bio’s flagship event knowledge for growth will be organized...
PDC*line Pharma CEO and COO will be in Amsterdam (The Netherlands), March 12–14, 2018 for the BIO-EUROPE SPRING 12th annual international partnering conference. Contact us for a face to face meeting...
Eric Halioua, President & CEO of PDC*line Pharma will present the company at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event organized, Feb. 26, 2018 in Hilton Zurich...
Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in the Advances in Cell & Gene Therapies round table at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event...
PDC*line Pharma CEO and COO will be in San Francisco (USA) during the JP Morgan conference, January 8–10, 2017.
PDC*line Pharma’s CMO and CSO will be present at ESMO Immuno Oncology Congress in Geneva, Switzerland – 07 Dec – 10 Dec 2017. A poster will be presented describing our last results with Neo-Antigens...
Eric Halioua, President & CEO of PDC*line Pharma will be chairman at a roundtable session on “How to keep the founding scientists committed?” at BioFIT partnering event, Strasbourg (France) , November...
